RT Journal Article
SR Electronic
T1 Natural Language Processing for Automated Annotation of Medication Mentions in Primary Care Visit Conversations
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2021.03.29.21254488
DO 10.1101/2021.03.29.21254488
A1 Craig H Ganoe
A1 Weiyi Wu
A1 Paul J Barr
A1 William Haslett
A1 Michelle D Dannenberg
A1 Kyra L Bonasia
A1 James C Finora
A1 Jesse A Schoonmaker
A1 Wambui M Onsando
A1 James Ryan
A1 Glyn Elwyn
A1 Martha L Bruce
A1 Amar K Das
A1 Saeed Hassanpour
YR 2021
UL http://medrxiv.org/content/early/2021/03/31/2021.03.29.21254488.abstract
AB Objectives The objective of this study is to build and evaluate a natural language processing approach to identify medication mentions in primary care visit conversations between patients and physicians.Materials and Methods Eight clinicians contributed to a dataset of 85 clinic visit transcripts, and ten transcripts were randomly selected from this dataset as a development set. Our approach utilizes Apache cTAKES and Unified Medical Language System (UMLS) controlled vocabulary to generate a list of medication candidates in the transcribed text, and then performs multiple customized filters to exclude common false positives from this list while including some additional common mentions of the supplements and immunizations.Results Sixty-five transcripts with 1,121 medication mentions were randomly selected as an evaluation set. Our proposed method achieved an F-score of 85.0% for identifying the medication mentions in the test set, significantly outperforming existing medication information extraction systems for medical records with F-scores ranging from 42.9% to 68.9%.Discussion Our medication information extraction approach for primary care visit conversations showed promising results, extracting about 27% more medication mentions from our evaluation set while eliminating many false positives in comparison to existing baseline systems. We made our approach publicly available on the web as an open-source software.Conclusion Integration of our annotation system with clinical recording applications has the potential to improve patients’ understanding and recall of key information from their clinic visits, and, in turn, to positively impact health outcomes.Competing Interest StatementNo conflicts to declare: CHG, WW, PJB, WH, MDD, KLB, JCF, JAS, WMO, JR, MLB, AKD, SH. GE: Glyn Elwyn has edited and published books that provide royalties on sales by the publishers: the books include Shared Decision Making (Oxford University Press) and Groups (Radcliffe Press). Glyn Elwyn's academic interests are focused on shared decision making and coproduction. He owns copyright in measures of shared decision making and care integration, namely collaboRATE, integRATE (measure of care integration, consideRATE (patient experience of care in serious illness), coopeRATE (measure of goal setting), incorpoRATE (clinician attitude to shared decision making, Observer OPTION-5 and Observer OPTION-12 (observer measures of shared decision making). He has in the past provided consultancy for organizations, including: 1) Emmi Solutions LLC who developed patient decision support tools; 2) National Quality Forum on the certification of decision support tools; 3) Washington State Health Department on the certification of decision support tools; 4) SciMentum LLC, Amsterdam (workshops for shared decision making). He is the Founder and Director of &think LLC which owns the registered trademark for Option GridsTM patient decision aids; Founder and Director of SHARPNETWORK LLC, a provider of training for shared decision making. He provides advice in the domain of shared decision making and patient decision aids to: 1) Access Community Health Network, Chicago (Adviser to Federally Qualified Medical Centers); 2) EBSCO Health (Consultant); 3) Bind On-Demand Health Insurance (Consultant), 4) PatientWisdom Inc (Adviser); 5) abridge AI Inc (Chief Clinical Research Scientist)Funding StatementResearch reported in this publication was supported by the National Library of Medicine of the National Institutes of Health under award number [R01 LM012815] and the Gordon & Betty Moore Foundation under award number [GBMF-4952]. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health or the Gordon and Betty Moore Foundation.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:This study and the use of human subject data in this project were approved by the committee for the Protection of Human Subjects at Dartmouth College (CPHS STUDY#30126) with informed consent.All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesThe dataset used in this study includes patient health identifiers and is not publicly available.